The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity
- PMID: 15544917
- DOI: 10.1016/j.freeradbiomed.2004.08.012
The importance of high-density lipoproteins for paraoxonase-1 secretion, stability, and activity
Abstract
The association of paraoxonase-1 (PON1) with high-density lipoproteins (HDL) is a prerequisite for maintaining normal serum activity of the enzyme. The lipoprotein furnishes an amphipathic environment to shield the hydrophobic, N-terminal region of the enzyme, and such an environment may also be necessary for interaction of PON1 with its substrates. HDL provides the optimal physiological acceptor complex, in terms of both stimulating PON1 secretion and stabilizing the secreted peptide. Lipid and peptide components of HDL contribute to these effects, such that modulating HDL composition influences PON1 activity and function. In this context, understanding how PON1 associates with HDL, what governs the association, and the mechanism by which the PON1-HDL complex exerts its antioxidant function is of particular physiological relevance. Moreover, HDL is subject to substantial compositional variations under both normal and pathological metabolic conditions. It has implications for the influence of the enzyme on cardiovascular risk, as normal enzyme activity may not correlate with optimal functional (antioxidant) efficiency. We review evidence that HDL lipid and protein components interact to promote PON1 secretion and maintain serum enzyme activity. Emerging data on how the enzyme associates with HDL are discussed, and the consequences for PON1 function of modifications to HDL are outlined. Finally, we highlight questions concerning the HDL-PON1 association that remain unanswered but are of particular importance in defining PON1 efficiency.
Similar articles
-
Variation in paraoxonase-1 activity and atherosclerosis.Curr Opin Lipidol. 2009 Aug;20(4):265-74. doi: 10.1097/MOL.0b013e32832ec141. Curr Opin Lipidol. 2009. PMID: 19550323 Review.
-
ApoE induces serum paraoxonase PON1 activity and stability similar to ApoA-I.Biochemistry. 2010 Jan 26;49(3):532-8. doi: 10.1021/bi9013227. Biochemistry. 2010. PMID: 20025294
-
Paraoxonase 1 (PON1) is a more potent antioxidant and stimulant of macrophage cholesterol efflux, when present in HDL than in lipoprotein-deficient serum: relevance to diabetes.Atherosclerosis. 2006 Jul;187(1):74-81. doi: 10.1016/j.atherosclerosis.2005.08.026. Epub 2005 Oct 17. Atherosclerosis. 2006. PMID: 16229851
-
Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells.Atherosclerosis. 2005 Mar;179(1):17-25. doi: 10.1016/j.atherosclerosis.2004.08.039. Epub 2004 Dec 7. Atherosclerosis. 2005. PMID: 15721005
-
[The antioxidant function of high density lipoproteins: a new paradigm in atherosclerosis].Rev Esp Cardiol. 2004 Jun;57(6):557-69. Rev Esp Cardiol. 2004. PMID: 15225502 Review. Spanish.
Cited by
-
Altered inflammation, paraoxonase-1 activity and HDL physicochemical properties in obese humans with and without Prader-Willi syndrome.Dis Model Mech. 2012 Sep;5(5):698-705. doi: 10.1242/dmm.009209. Epub 2012 Jul 19. Dis Model Mech. 2012. PMID: 22822045 Free PMC article.
-
Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis.Arthritis Res Ther. 2008;10(4):213. doi: 10.1186/ar2471. Epub 2008 Aug 29. Arthritis Res Ther. 2008. PMID: 18828865 Free PMC article. Review.
-
Increased inflammatory markers with altered antioxidant status persist after clinical recovery from severe sepsis: a correlation with low HDL cholesterol and albumin.Clin Exp Med. 2016 Nov;16(4):557-569. doi: 10.1007/s10238-015-0390-1. Epub 2015 Sep 28. Clin Exp Med. 2016. PMID: 26416404
-
Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes.Oxid Med Cell Longev. 2018 Nov 5;2018:1752940. doi: 10.1155/2018/1752940. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 30524650 Free PMC article.
-
Decreased paraoxonase activity in critically ill patients with sepsis.Clin Exp Med. 2010 Mar;10(1):21-5. doi: 10.1007/s10238-009-0059-8. Epub 2009 Sep 4. Clin Exp Med. 2010. PMID: 19760042
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous